Table 5.
Risk factors | Nstudy | Ncontrol | Luminal |
ER-PR- |
PH1b | Nstudy | Ncontrol | HER2-enriched |
Triple-negative |
PH2c | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ncase | ORpooled | Pha | Ncase | ORpooled | Pha | Ncase | ORpooled | Pha | Ncase | ORpooled | Pha | |||||||
BMI, kg/m2 | ||||||||||||||||||
<18.5 | 3 | 415 | 110 | 1.00 | 35 | 1.00 | – | – | – | – | – | – | – | – | ||||
18.5–24.9 | 3 | 4210 | 1432 | 1.20 (0.96–1.49) | 0.68 | 553 | 1.43 (1.00–2.05) | 0.57 | 0.66 | – | – | – | – | – | – | – | – | |
≥25 | 3 | 1349 | 534 | 1.75 (1.30–2.35) | 0.22 | 191 | 1.95 (1.04–3.65) | 0.07 | 0.87 | – | – | – | – | – | – | – | – | |
Ptrend<0.001d | Ptrend = 0.03d | |||||||||||||||||
Menopausal age, years | ||||||||||||||||||
<50 | 3 | 1261 | 547 | 1.00 | 260 | 1.00 | – | – | – | – | – | – | – | – | ||||
≥50 | 3 | 1363 | 682 | 1.15 (1.00–1.32) | 0.26 | 369 | 1.19 (1.00–1.43) | 0.06 | 0.32 | – | – | – | – | – | – | – | – | |
Age at menarche, years | ||||||||||||||||||
>12 | 4 | 5968 | 2146 | 1.00 | 948 | 1.00 | 3 | 3773 | 265 | 1.00 | 505 | 1.00 | ||||||
≤12 | 4 | 1307 | 525 | 1.39 (1.23–1.57) | 0.28 | 168 | 1.20 (0.91–1.58) | 0.11 | 0.01 | 3 | 616 | 28 | 0.76 (0.50–1.16) | 0.15 | 59 | 1.28 (0.94–1.73) | 0.76 | 0.001 |
Parity | ||||||||||||||||||
≥1 | 6 | 10,604 | 5032 | 1.00 | 2012 | 1.00 | 4 | 4684 | 364 | 1.00 | 730 | 1.00 | ||||||
0 | 6 | 771 | 408 | 1.26 (1.11–1.44) | 0.14 | 128 | 1.03 (0.84–1.26) | 0.28 | 0.04 | 4 | 406 | 38 | 1.02 (0.70–1.47) | 0.19 | 50 | 1.34 (0.96–1.85) | 0.66 | 0.10 |
Age at first live birth, years | ||||||||||||||||||
<25 | 5 | 3829 | 1592 | 1.00 | 821 | 1.00 | 3 | 1628 | 119 | 1.00 | 306 | 1.00 | ||||||
≥25 | 5 | 6087 | 3093 | 1.14 (0.86–1.52)e | <0.001 | 1149 | 0.83 (0.62–1.10)e | <0.001 | <0.001 | 3 | 2443 | 160 | 0.93 (0.56–1.56)e | <0.001 | 361 | 0.80 (0.56–1.14)e | <0.001 | <0.001 |
Breastfeeding | ||||||||||||||||||
Yes | 5 | 8430 | 3806 | 1.00 | 1529 | 1.00 | 3 | 3626 | 222 | 1.00 | 585 | 1.00 | ||||||
No | 5 | 1579 | 851 | 1.35 (1.05–1.74)e | <0.001 | 186 | 1.74 (1.41–2.15) | 0.23 | <0.001 | 3 | 484 | 48 | 1.97 (1.39–2.80) | 0.23 | 78 | 1.85 (1.06–3.21)e | 0.02 | 0.07 |
P-values (two-sided) were based on a Q-test of heterogeneity between included studies.
PH1: P-value of heterogeneity of exposure-disease ORs among luminal and ER−/PR− subtypes.
PH2: P-value of heterogeneity of exposure-disease ORs among luminal, HER2-enriched and triple-negative subtypes.
P-value for trends calculated by trend chi-square.
The pooled odds ratio was calculated by a random-effects model.